UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026722 |
|---|---|
| Receipt number | R000030675 |
| Scientific Title | Phase II trial of docetaxel+cisplatin+capecitabine (DCX) therapy for unresectable or recurrent HER2-negative gastric cancer |
| Date of disclosure of the study information | 2017/05/01 |
| Last modified on | 2023/04/01 14:46:30 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/03/27 19:26:58 | ||
| 2 | Update | 2018/03/28 13:28:58 | Recruitment status |
|
| 3 | Update | 2022/03/31 09:51:33 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 4 | Update | 2023/04/01 14:46:30 | Recruitment status |
